je.st
news
FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...
2013-09-28 10:29:05| Biotech - Topix.net
International drug manufacturer Actavis, Inc. has agreed to sell all rights and assets to four generic pharmaceuticals - three oral contraceptives and an osteoporosis treatment - to settle FTC charges that its proposed $8.5 billion acquisition of drug-maker Warner Chilcott plc would be anticompetitive.
Tags: proposed
charges
billion
acquisition
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||